Print

Journal of Virology Publication Highlights Antiviral Activity Of AVI BioPharma's (AVII) NEUGENE Antisense Compound 
10/19/2005 5:11:28 PM

AVI BioPharma, Inc. (Nasdaq:AVII), today announced publication of positive preclinical data relating to its NEUGENE(R) antisense compound in the June issue of the Journal of Virology.
//-->